financetom
Market
financetom
/
Market
/
Paytm, Bajaj Electricals, and Hero MotoCorp: Key stocks that moved the most on March 23
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Paytm, Bajaj Electricals, and Hero MotoCorp: Key stocks that moved the most on March 23
Mar 23, 2022 8:01 AM

Paytm, Bajaj Electricals, and Hero MotoCorp: Key stocks that moved the most on March 23

SUMMARY

Benchmark indices ended lower with Nifty below 17,300 in the volatile session on Wednesday. At close, the Sensex was down 0.53 percent at 57,684.82, and the Nifty was down 0.40 percent at 17,245.70. Here are the key stocks that moved the most in trade today:

By CNBCTV18.comMar 23, 2022 4:02:59 PM IST (Updated)

Paytm | Share price of One 97 Communications, the parent firm of Paytm, rose over 3 percent in the early trade today after the company clarified on the BSE query. The BSE on March 22 sought clarification from One 97 Communications, over the sharp fall in its share prices. The shares, however, ended 4 percent lower.

Bajaj Electricals | Bajaj Electricals share price edged higher by over 2 percent intraday on Wednesday after the company renewed trade licensing agreement with Morphy Richards for 15 years. The shares closed at 1.31 percent higher.

Hero MotoCorp | Hero MotoCorp share price slipped 4 percent intraday today after the Income Tax (I-T) department conducted search operations at the company's 25 premises. The department is conducting the search operations at the offices and residences of Hero MotoCorp senior management in Delhi, Gururgram and in other parts of North India. The shares of the company ended 1.37 percent lower.

Indian Hotels | A meeting of the QIP Committee of the board of directors of Indian Hotels Company is scheduled to be held on March 25 to consider and approve the issue price, including a discount, if any, for the equity shares to be allotted to qualified institutional buyers. The shares ended 3.50 percent higher.

Gland Pharma | Jefferies kept a 'buy' rating on Gland Pharma with a target at Rs 4,578 per share. Jefferies hosted Gland Pharma for a UK/EU roadshow recently. The management guided growth visibility in all key markets. The company expects 20-25 percent revenue CAGR in the medium term, while margin is expected to be steady with volume growth countering gross margin dilution. Shares of the company ended 2.35 percent higher.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved